Menu
← Oncology Approval Tracker
FDA DECISION ·
Padcev
enfortumab vedotin-ejfv · Astellas Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with locally advanced or metastatic urothelial carcinoma after both a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy.
LAMPGEN ANALYSIS
Why it matters
This converts the post-platinum and checkpoint inhibitor population from accelerated to traditional approval.
What research teams should watch
Capture prior treatment class and timing, with consistent follow-up for neuropathy and skin reactions.
PRIMARY RECORDS